Today’s Research Reports on Trending Tickers: Cascadian Therapeutics and UnitedHealth Group

NEW YORK, NY / ACCESSWIRE / February 8, 2018 / On Wednesday, U.S. markets failed to continue on Tuesday’s gains as investors worried about rising bond yields and interest rates. The Dow Jones Industrial Average dipped 0.08 percent to close at 24,893.35, while the S&P 500 Index fell 0.50 percent to close at 2,681.66. The Nasdaq Composite Index dropped 0.90 percent to close at 7,051.98.

“The market was positioned for great earnings, great growth, and no inflation or rates moving up to any meaningful degree. Now that goldilocks environment is gone, and we’re back in a normal environment where we’re getting both strong growth and higher rates. That readjustment is bringing some jitters,” said Alec Young, managing director of global markets research at FTSE Russell.

RDI Initiates Coverage on:

Cascadian Therapeutics, Inc.
https://rdinvesting.com/news/?ticker=CASC

UnitedHealth Group Inc.
https://rdinvesting.com/news/?ticker=UNH

Cascadian Therapeutics’ stock edged 0.20% lower Wednesday, to close the day at $9.98. The stock recorded a trading volume of 1,127,636 shares, which was above its three months average volume of 819,764 shares. In the last year, Cascadian Therapeutics’ shares have traded in a range of 3.18 – 10.21. The share price has gained 213.84% from its 52 week low. The company’s shares are currently trading above their 200-day moving average. The stock’s 50-day moving average of $5.03 is greater than its 200-day moving average of $4.23. Shares of Cascadian Therapeutics have gained roughly 174.18 percent in the past month and are up 169.73 percent year-to-date.

Access RDI’s Cascadian Therapeutics, Inc. Research Report at:
https://rdinvesting.com/news/?ticker=CASC

On Wednesday, shares of UnitedHealth Group recorded a trading volume of 5,589,154 shares, which was above the three months average volume of 3,104,511 shares. The stock ended the day 0.28% higher at 225.82. The share price has gained 44.30% from its 52 week low with a 52 week trading range of 156.49 – 250.79. The company’s shares are currently trading above their 200-day moving average. The stock’s 50-day moving average of $230.71 is greater than its 200-day moving average of $209.02. Shares of UnitedHealth are trading at a Price to Earnings ratio of 21.07. Shares of UnitedHealth Group have fallen roughly 1.27 percent in the past month and are up 2.43 percent year-to-date.

Access RDI’s UnitedHealth Group Inc. Research Report at:
https://rdinvesting.com/news/?ticker=UNH

Our Actionable Research on Cascadian Therapeutics, Inc. (NASDAQ:CASC) and UnitedHealth Group Inc. (NYSE:UNH) can be downloaded free of charge at Research Driven Investing.

Research Driven Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

Research Driven Investing, Unit #901 511 Avenue of the Americas, New York, NY, 10011

Email:

contact@rdinvesting.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: RDInvesting.com

ReleaseID: 488527